pentobarbital will minimize the level or outcome of larotrectinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.Barbiturates look to improve the metabolism of exogenous corticosteroids probably with the induction of hepatic microsomal enzymes. Patients stabilized on corticosteroid therapy could require dosage changes if barbiturates are